سعر اريثروسين 500مجم 12 قرص 2022

Erythrocin (Kahira / Abbott Laboratories): erythromycin 500 mg tablets, box of 12; macrolide antibiotic.

• Mild to moderate upper and lower respiratory tract infections caused by susceptible Streptococcus pyogenes or Streptococcus pneumoniae (H. influenzae only with concomitant sulfonamide).Population: Adults and childrenDailyMed (U.S. National Library of Medicine)
• Skin and skin structure infections of mild to moderate severity caused by susceptible Streptococcus pyogenes or Staphylococcus aureus; also diphtheria (adjunct to antitoxin), erythrasma, pertussis, Legionnaires disease, chlamydial and other listed infections.Population: Adults and childrenDailyMed (U.S. National Library of Medicine)
• Prevention of initial and recurrent attacks of rheumatic fever in penicillin-allergic patients.Population: Penicillin-allergic patientsDailyMed (U.S. National Library of Medicine)

• Most frequent: dose-related gastrointestinal effects (nausea, vomiting, abdominal pain, diarrhoea, anorexia). Also reported: hepatic dysfunction, allergic reactions from urticaria to anaphylaxis, rare severe skin reactions (erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis), and reversible hearing loss mainly with renal insufficiency or high doses.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to erythromycin.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Contraindicated in patients taking terfenadine, astemizole, pimozide or cisapride.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hepatic dysfunction, including increased liver enzymes and hepatocellular and/or cholestatic hepatitis with or without jaundice, has been reported with oral erythromycin.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• QT prolongation and ventricular arrhythmias including torsades de pointes have been reported; avoid in patients with known QT prolongation, uncorrected hypokalaemia or hypomagnesaemia, clinically significant bradycardia, or on class IA/III antiarrhythmics; elderly patients may be more susceptible.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Clostridioides difficile-associated diarrhoea has been reported with nearly all antibacterial agents and may range from mild diarrhoea to fatal colitis.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• TheophyllineHigh-dose theophylline levels may rise with possible toxicity; reduce theophylline dose if needed.DailyMed (U.S. National Library of Medicine)
• DigoxinElevated digoxin serum levels have been reported.DailyMed (U.S. National Library of Medicine)
• Oral anticoagulants (e.g. warfarin)Increased anticoagulant effect, possibly more pronounced in the elderly.DailyMed (U.S. National Library of Medicine)

• Animal reproduction studies in rats showed no evidence of teratogenicity; there are no adequate and well-controlled studies in pregnant women, so use during pregnancy only if clearly needed.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Erythromycin is excreted in human milk; use with caution in nursing women.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Erythromycin: Macrolide antibacterial: binds the 50S ribosomal subunit of susceptible organisms and inhibits protein synthesis; it does not affect nucleic acid synthesis.